Structural basis of multimer-mediated mayhem

Slides:



Advertisements
Similar presentations
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Advertisements

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer Min Ni, Yiwen Chen, Elgene Lim, Hallie Wimberly, Shannon T. Bailey, Yuuki Imai,
Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia Bin Zhang, Yin Wei Ho, Qin Huang, Takahiro Maeda,
C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells Roger R. Gomis, Claudio Alarcón, Cristina Nadal, Catherine.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
The Metabolic Basis of Pulmonary Arterial Hypertension Gopinath Sutendra, Evangelos D. Michelakis Cell Metabolism Volume 19, Issue 4, Pages (April.
Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity Cai-Hong.
The Mitochondrial Basis of Aging Nuo Sun, Richard J. Youle, Toren Finkel Molecular Cell Volume 61, Issue 5, Pages (March 2016) DOI: /j.molcel
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Mutually Exclusive Binding of Telomerase RNA and DNA by Ku Alters Telomerase Recruitment Model Jennifer S. Pfingsten, Karen J. Goodrich, Cornelius Taabazuing,
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin Malay Haldar, Jeffrey D. Hancock, Cheryl M. Coffin, Stephen L. Lessnick,
New Views into the Prostate Cancer Genome
Volume 7, Issue 3, Pages (March 2005)
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Metastasis gets site specific
An Alternative Sugar Fuels AML
The Ids Have It Cancer Cell
Mutant p53 gain of function: The NF-Y connection
A Time to Divide: Does the Circadian Clock Control Cell Cycle?
Multiple Effects of Angiopoietin-2 Blockade on Tumors
Andrew G. Muntean, Jay L. Hess  Cancer Cell 
CALming Down T Cell Acute Leukemia
Killing Tumors by Keeping Ras and PI3′ Kinase Apart
A Sweet New Role for EGFR in Cancer
Tumor Evolution: A Problem of Histocompatibility
Actin and Microtubules: Working Together to Control Spindle Polarity
MDS Is a Stem Cell Disorder After All
Volume 26, Issue 1, Pages 1-2 (July 2014)
Eun-Jung Jung, George A. Calin  Cancer Cell 
Jay Kumar Singh, William E. Balch  Developmental Cell 
The Wind God Promotes Lung Cancer
Alyson A. Lokken, Nancy J. Zeleznik-Le  Cancer Cell 
ABT-199: Taking Dead Aim at BCL-2
Can Treating the SYK Cell Cure Leukemia?
CALming Down T Cell Acute Leukemia
Wnt/β-Catenin Signaling: Turning the Switch
Combinatorial Haplo-Deficient Tumor Suppression in 7q-Deficient Myelodysplastic Syndrome and Acute Myeloid Leukemia  Britta Will, Ulrich Steidl  Cancer.
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
Giulio Francia, Urban Emmenegger, Robert S. Kerbel  Cancer Cell 
RalGDS comes of age Cancer Cell
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy  Laurence Blavier, Yves A. DeClerck 
Proteins Kinases: Chromatin-Associated Enzymes?
Multiple Effects of Angiopoietin-2 Blockade on Tumors
Retrovirus Silencing by an Epigenetic TRIM
A common pathway for genetic events leading to pheochromocytoma
RIPK3 Slams the Brake on Leukemogenesis
To Infinium, and Beyond! Cancer Cell
Volume 10, Issue 3, Pages (September 2006)
The TRIP from ULF to ARF Cancer Cell
ATMIN: A New Tumor Suppressor in Developing B Cells
Searching for leukemia stem cells—Not yet the end of the road?
There's a Time and a Place for MYCN
Ewing's sarcoma: General insights from a rare model
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Ibrutinib Treatment of CLL: The Cancer Fights Back
New Myc-anisms for DNA Replication and Tumorigenesis?
Volume 12, Issue 6, Pages (December 2007)
In This Issue Cell Volume 145, Issue 3, (April 2011)
The Ups and Downs of Src Regulation: Tumor Suppression by Cbp
Presentation transcript:

Structural basis of multimer-mediated mayhem Kajal V. Sitwala, Jay L. Hess  Cancer Cell  Volume 9, Issue 4, Pages 241-242 (April 2006) DOI: 10.1016/j.ccr.2006.03.022 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Functional consequences of AML1-ETO tetramer formation The AML1-ETO monomer (top) is capable of binding to target loci and recruiting corepressors and deacetylases (N-CoR, mSin3A, SMRT, HDAC1–HDAC3) but is nontransforming. Oligomerization of AML1-ETO (bottom) allows recruitment of additional ETO family members and confers transforming capability. Other mechanisms to be defined may also contribute to the leukemogenicity of the oligomer, including altered DNA binding affinity, recruitment of additional corepressors, or increased local corepressor concentration. Cancer Cell 2006 9, 241-242DOI: (10.1016/j.ccr.2006.03.022) Copyright © 2006 Elsevier Inc. Terms and Conditions